In fact, LRG1 has been shown to promote cardiovascular disease by regulating endothelial dysfunction and inflammation through TGF-β and SMAD1/5/8 signaling in endothelial cells, interrupting normal endothelium-dependent vasodilation and availability of nitric oxide (129). Here, LRG1 is linked to cardiovascular disorder.